ArticleInternational journal of biological macromolecules2026
Parallel in-register contact propensity predicts the Amyloidogenicity of ADan and ABri in familial dementias.
Article in International journal of biological macromolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Familial Danish dementia (FDD) and British dementia (FBD) are rare neurodegenerative diseases caused by stop-codon mutations in the Bri2 gene, leading to amyloid deposits formed by the aggregation of mutant ADan and ABri peptides, respectively. FDD symptoms usually manifest decades earlier than those of FBD. Probably due to the rarity of these conditions, the aggregation mechanisms of ADan and ABri and the molecular basis for FDD's earlier onset remain underexplored. Here, we computationally investigated the conformational dynamics of monomeric wild-type Bri23 and the two mutants ADan and ABri, as well as their self-assembly dynamics from dimers to hexamers using atomistic discrete molecular dynamics simulations. Our results aligned with earlier experimental work on the monomeric structures. We also confirmed that Bri23 is less amyloidogenic, showing significantly lower self-assembly propensity compared to ADan and ABri, which both favored forming β-sheet-rich oligomers. In amyloid aggregation, the critical nucleation event involves the transition from unaligned or misaligned oligomers to well-aligned fibril seeds featuring parallel in-register (PAIR) intermolecular β-sheets - the structural hallmark of mature fibrils. Notably, ADan showed a higher propensity than ABri to form longer PAIR intermolecular β-sheets within oligomers, suggesting a lower fibril nucleation barrier (i.e., higher amyloidogenicity) and thereby explaining FDD's earlier onset. We further identified nucleation "hotspots" with high PAIR propensities in both ADan and ABri, which may serve as potential therapeutic targets. Together, these insights into the early aggregation dynamics of these rare dementias enhance our understanding of the aggregation-nucleation process and disease mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.